uMETHOD Health

Announcement for Clinicians! Earn up to 22 CME credits to learn the latest technologies, diagnostics, and innovative treatments for dementia.
Collaborating with Quest Diagnostics and The Physician Transformation Institute, this is an opportunity to revolutionize the way we approach dementia care over 2 days.
Gain valuable insights on workflow optimization, billing, and coding as well as collaborative medicine and the Medicare Guide model.
Proceeds go toward designing anonymous mental health services for physicians and other healthcare professionals suffering from burnout.

Demystifying Dementia for Healthcare Professionals Join healthcare professionals at the cutting-edge Demystifying Dementia Program in Houston, TX. Explore new test such as the Amyloid 42/40 test from Quest Diagnostics, game-changing AI tools, and Group Visit modalities for memory care & dementia management. 22 AMA PRA Category 1 CME.

📣 Exciting news from the ! Our founder, John Walker, represents uMETHOD, sharing groundbreaking insights on personalized healthcare. Be sure to watch him live at https://www.usa2summit.org/
Here are the key highlights he will hit on at 2:30pm EST.

uMETHOD Health creates personalized care plans for doctors, answering the crucial question: "Just Tell Me What to Do Now." These plans are based on 30 years of research and studies, translating complex data into actionable guidance for doctors, patients, and families.

By taking a comprehensive approach, uMETHOD Health intercepts cognitive decline at any stage: prevention, early symptoms, or progression. Doctors order a uMETHOD panel during lab tests, collecting over 100 biomarkers. Raw data, along with medical history, is analyzed by uMETHOD's software engine to generate care plans in simplified language for patients.

Multimorbidity and polypharmacy are common challenges. 80% of individuals have three or more chronic diseases. uMETHOD considers these conditions in its calculations, recognizing that cognitive issues are intertwined with overall health.

The engine also assesses medications. On average, patients take ten drugs, often causing brain fog or increasing the risk of falling. uMETHOD quantifies the cognitive impact of each drug and suggests alternatives. It identifies medications that exacerbate existing chronic conditions, like nephrotoxic drugs affecting kidney disease.

uMETHOD's care plans include the latest drug insights, such as Leqembi, and are fully reimbursed by Medicare. Over 10,000 individuals have benefited from uMETHOD's personalized approach.

Stay tuned for more updates as uMETHOD Health continues to redefine healthcare, making personalized medicine accessible to all. Together, let's create a cognitive blueprint🌐

Visit our booth at the PriMed Conference to meet our talented team members, Staccey, Frank, and Martina! They will be there today and tomorrow to connect with over 165,000+ active primary care clinicians. Learn how our company is revolutionizing personal care plans for patients in the dementia and Alzheimer's space. Don't miss out!

Did you attend the event?

We had the incredible opportunity to engage and connect with providers, discussing care pathways that can truly make a difference in improving patient outcomes. 🏥

One of the highlights was our discussion on the CMS guide, which presents a unique opportunity to enhance the quality of care for individuals living with dementia and Alzheimer's. By leveraging these guidelines, we can ensure that every patient receives the highest standard of care and support.

Together, let's continue to collaborate, innovate, and drive positive change in healthcare. By working hand in hand with providers, we can make a lasting impact on the lives of those affected by dementia and their families. 🤝